The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating causes of screen failure (SF) in non-small cell lung cancer (NSCLC) clinical trials requiring specific biomarker (BioM) results for enrollment.
 
Danielle J. Nameth
No Relationships to Disclose
 
Jonathan Wade Goldman
Research Funding - ArQule; Astex Pharmaceuticals; Bristol-Myers Squibb; Clovis Oncology; Genentech/Roche; Lilly; Synta
 
Brian R. Wolf
No Relationships to Disclose
 
Deborah Jean Lee Wong
No Relationships to Disclose
 
Blanca A. Ledezma
No Relationships to Disclose
 
Melody A. Mendenhall
No Relationships to Disclose
 
Olayinka Oshodi
No Relationships to Disclose
 
Steven R. Carrasco
No Relationships to Disclose
 
Carlos R. Adame
No Relationships to Disclose
 
Phillip A. Abarca
No Relationships to Disclose
 
Mary Han
No Relationships to Disclose
 
William Sago
No Relationships to Disclose
 
Marshall L. Spiegel
No Relationships to Disclose
 
John M. Horton
No Relationships to Disclose
 
Darren D. Pan
No Relationships to Disclose
 
Daria Gaut
No Relationships to Disclose
 
Carmel Diamant
No Relationships to Disclose
 
Sarah M. Rosales
No Relationships to Disclose
 
Edward B. Garon
Consulting or Advisory Role - Boehringer Ingelheim (Inst)
Research Funding - AstraZeneca (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst)